Genesis 2025 keynote panel: How will new medicines be delivered and paid for in 2050?
About Genesis
Genesis 2025 has been a fixture in the life sciences calendar for over two decades. It brings together key opinion leaders, investors, and innovators to share insights, and discuss trends.
Under the headline theme: Maximising Returns from Life Science Innovation, Genesis 2025 promises a dynamic program and networking opportunities.
Event highlights
- High-impact keynote talks and panel discussions featuring leading voices in Life Sciences
- NEW Company Showcase spotlighting emerging R&D companies
- Networking with delegates throughout the day
- 1-to-1 meetings via the event app
- Plus, look out for the Genesis Fringe events for informal, in-person networking
- Exhibition Area
Panel discussion
Will Arends is chairing a keynote panel: How will new medicines be delivered and paid for in 2050? Joining him for the discussion is:
• Melanie Leveridge, Astra Zenica
• Lisa Urquhart
• Pierre Arsene, Mursla Bio
• Nara Daubeney, Phaim Pharma
• Pervaise Khan, EY.
Time of the panel discussion:11.05am
Find out more and to register click here
Will Arends
Partner
Chartered (UK) and European Patent Attorney, UPC Representative
Will is a Chartered (UK) and European Patent Attorney and has dealt with a wide range of subject matter in life sciences including fields such as immunology, molecular biology and medical devices, as well as non-medical subject matter such as plant biotechnology, DNA security tagging, and food technology.
Upcoming events
The Scottish Knowledge Exchange Awards
Nominations for the 11th Scottish Knowledge Exchange Awards (SKEA) are now open.
Read more
Genesis 2025 keynote panel. How will new medicines be delivered and paid for in 2050?
Genesis 2025 - Maximising Returns from Life Science Innovation brings together brings together key opinion leaders, investors, and innovators to share insights.
Read more